Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali

Background. The monovalent meningococcal A conjugate vaccine (PsA-TT, MenAfriVac) was developed for use in the “meningitis belt” of sub-Saharan Africa. Mali was 1 of 3 countries selected for early introduction. As this is a new vaccine, postlicensure surveillance is particularly important to identif...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Vannice, Kirsten S., Keita, Modibo, Sow, Samba O., Durbin, Anna P., Omer, Saad B., Moulton, Lawrence H., Yaméogo, Téné M., Zuber, Patrick L. F., Onwuchekwa, Uma, Sacko, Massambou, Diomandé, Fabien V. K., Halsey, Neal A.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639483/
https://ncbi.nlm.nih.gov/pubmed/26553680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ497
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados